サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1565003

ヘルペスマーカー検査の世界市場

Herpes Marker Testing

出版日
ページ情報
英文 159 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ヘルペスマーカー検査の世界市場
出版日: 2024年10月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 159 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヘルペスマーカー検査の世界市場は2030年までに6億5,410万米ドルに達する見込み

2023年に4億6,810万米ドルと推定されたヘルペスマーカー検査の世界市場は、2030年には6億5,410万米ドルに達し、分析期間2023-2030年のCAGRは4.9%で成長すると予測されます。本レポートで分析したセグメントの1つである診断センターエンド用途は、CAGR 5.7％を記録し、分析期間終了までに2億7,990万米ドルに達すると予測されます。病院エンドユーズ分野の成長率は、分析期間中CAGR 4.6%と推定されます。

米国市場は1億2,410万米ドルと推定、中国はCAGR7.5%で成長すると予測

米国のヘルペスマーカー検査市場は、2023年に1億2,410万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGRを7.5%として、2030年までに1億4,570万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.4％と4.6％と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界のヘルペスマーカー検査市場- 主要動向と促進要因のまとめ

ヘルペスマーカー検査はウイルス感染を効果的に管理する鍵となるか？

ヘルペスマーカー検査は単純ヘルペスウイルス（HSV）感染の診断と管理において重要な役割を果たしていますが、なぜこの検査が不可欠なのでしょうか？ヘルペスマーカー検査は、体内の抗体またはウイルスDNAの存在を検出するために使用され、臨床医がHSV-1またはHSV-2の2つの最も一般的なウイルス株に感染しているかどうかを特定するのに役立ちます。HSV-1は一般的に口唇ヘルペス（冷え症）に関連し、HSV-2は性器ヘルペスに関連するが、どちらの型もどちらの部位にも感染する可能性があります。ヘルペス感染症は広く蔓延しており、世界中で何百万人もの人々がいずれかの型のウイルスに感染して生活しています。その多くは無症状であることが多いため、自分がキャリアであることに気づいていません。

ヘルペスマーカー検査は、特に無症状の人や症状が軽い人が、知らず知らずのうちに他の人にウイルスを感染させている可能性があるため、ウイルスを診断するために非常に重要です。ヘルペスの検査では、免疫系が感染に反応して産生する特異的な抗体（IgGまたはIgM）を同定するか、ポリメラーゼ連鎖反応（PCR）検査によってウイルスDNAを検出します。これらの検査は、誰かがウイルスに暴露されたかどうかを確認するのに役立ち、多くの場合、感染が最近か長期かを示すことができます。ヘルペスマーカー検査による正確な診断は、アウトブレイクを管理し、感染のリスクを低減し、個人の症状を管理し合併症を予防するための治療法を導くために不可欠です。

技術はどのようにヘルペスマーカー検査を進歩させたか？

技術の進歩は、ヘルペスマーカー検査をより正確に、より速く、よりアクセスしやすくするために、大きく改善しました。この分野における最も重要な技術革新の一つは、ウイルスDNAを直接検出できるポリメラーゼ連鎖反応（PCR）検査の開発です。PCR検査は非常に感度が高く、血液、唾液、病変部スワブなど様々なサンプルタイプから少量のウイルスでも検出することができます。この方法は、迅速かつ正確な結果を提供し、多くの場合数時間以内に、活動性ヘルペス感染を検出するための最も信頼性の高い診断ツールの1つとなっています。PCR検査は、HSV感染症の診断のためのゴールドスタンダードとなっており、特に急性の流行時など、確定診断が迅速に必要な場合に用いられています。

HSVに対する抗体の存在を確認する血清学的検査も進歩しています。従来の血液検査では、HSV-1とHSV-2感染の鑑別に苦労することがあった。しかし、最新の血清学的検査では、HSV-1型とHSV-2型に特異的な抗体を検出できるようになり、臨床医はHSV-1型とHSV-2型を区別できるようになった。HSV-1とHSV-2ではトランスミッションのパターンや再発率が異なるため、この区別は非常に重要です。型特異的IgG抗体検査は過去に感染したかどうかを示すことができ、IgM検査は最近または一次感染を識別するのに役立ちます。

さらに、ヘルペスのポイントオブケア（POC）検査がますます利用できるようになってきています。これらの迅速検査はその場で結果が得られるため、迅速診断が重要な急患診療所や性病診療所で有用です。新しい技術では、HSVと同時に複数の性感染症（STI）を検出できるマルチプレックス検査も開発されており、効率性が向上し、重複感染の診断に必要な検査回数が減少しています。ヘルペスマーカー検査のこれらの進歩は、診断精度を向上させるだけでなく、プロセスを迅速化し、ヘルペス感染の早期介入とより良い管理を可能にします。

なぜヘルペスマーカー検査が公衆衛生や個人管理に不可欠なのか？

ヘルペスマーカー検査は公衆衛生と個人管理にとって不可欠です。なぜなら、ヘルペスマーカー検査を使用することで、個人とヘルスケアプロバイダーが単純ヘルペスウイルス感染を検出し、特に症状が軽度であったり、症状がない場合に、感染の拡大を抑制することができるからです。ヘルペスウイルスは長期間体内に潜伏し、ストレス、病気、免疫力の低下などの要因によって初めて発症するため、ヘルペス感染者の多くは感染に気づいていません。適切な検査を行わないと、このような人は知らず知らずのうちに他の人にウイルスを感染させ、感染の拡大につながる可能性があります。ヘルペスマーカーの検査は、キャリアを特定し、抗ウイルス薬の使用やより安全な性行為の実践など、感染のリスクを減らすための予防措置をとるのに役立ちます。

特に、性器や口腔のただれ、かゆみ、不快感などの原因不明の症状を経験している場合、ヘルペスマーカー検査は個人にとって明確な安心感をもたらします。確定診断により、ヘルスケアプロバイダーは、アシクロビル、バラシクロビル、またはファムシクロビルなどの抗ウイルス薬を含む、発生頻度や重症度を減らすためのオーダーメイドの管理計画を立てることができます。自分のHSVの状態を知ることは、特にウイルスがまだ感染する可能性のある無症候性排泄の間、性的パートナーにウイルスを感染させないための予防措置を講じる力にもなります。

妊婦の場合、ヘルペスマーカー検査は特に重要です。HSV感染症は、特に妊娠中に発症した場合、赤ちゃんにリスクをもたらす可能性があり、新生児ヘルペスにつながる可能性があります。ヘルペス感染を早期に発見することで、医師は、妊娠後期に抗ウイルス薬を処方したり、分娩中に活動性の病変があれば帝王切開分娩を勧めるなどの予防措置を講じることができ、新生児にウイルスを感染させるリスクを減らすことができます。

より大きな規模では、HSV感染症が公衆衛生に及ぼす影響全体を管理するために、ヘルペスマーカー検査は極めて重要です。このウイルスは、世界的に最も流行している性感染症の1つであり、広く検査を行うことで、保菌者を特定し治療することでトランスミッション率を低下させることができます。ヘルペス感染症の早期発見と効果的な管理は、検査や治療を受けることを妨げるウイルスに関連する偏見を減らすことにも役立ちます。検査を正常化し、診断への容易なアクセスを提供することにより、公衆衛生システムはHSVの蔓延をより効果的に管理し、脆弱な集団を保護し、ウイルスとともに生きる人々の生活の質を向上させることができます。

ヘルペスマーカー検査市場の成長を促進する要因は？

ヘルペスマーカー検査市場の成長は、性感染症（STI）に対する意識の高まり、検査技術の進歩、単純ヘルペスウイルス感染の世界の有病率の増加など、いくつかの重要な要因によって牽引されています。主な促進要因の一つは、STIに対する意識の高まりと定期的なスクリーニングの重要性です。公衆衛生キャンペーンや教育プログラムは、特にHSV感染の無症状性についての認識が高まるにつれて、より多くの人々にヘルペスやその他のSTIの検査を受けるよう促しています。このような公衆衛生意識の変化は、診療所、病院、家庭用検査キットにおけるヘルペスマーカー検査の需要の高まりにつながっています。

診断検査における技術の進歩も、ヘルペスマーカー検査市場の成長に寄与しています。PCR検査やマルチプレックス検査など、より正確で迅速かつ費用対効果の高い検査の開発により、ヘルペス診断はヘルスケアプロバイダーや患者にとってより身近なものとなっています。これらの技術により、迅速な対応が可能となり、これは特に急性アウトブレイクの管理やトランスミッションの予防において重要です。迅速な結果が得られるPOC（ポイント・オブ・ケア）検査のイントロダクションも市場拡大を後押しする要因の一つであり、特にヘルスケア・インフラが限られている地域や、治療方針の決定に即時結果が必要な地域では重要です。

ヘルペス感染症の有病率が上昇していることも、市場の成長を促す重要な要因です。世界保健機関（WHO）は、50歳未満の37億人以上がHSV-1に感染しており、15～49歳の4億9,000万人以上がHSV-2に感染していると推定しています。これらの感染症が依然として蔓延し不治の病であるため、ヘルペス感染を管理・監視するための効果的な診断ツールに対する需要は増加の一途をたどっています。妊娠中の合併症やHIVトランスミッションのリスク上昇など、未診断または未治療のヘルペスに関連する健康リスクに対する認識が高まっているため、検査を求める人が増えています。

在宅検査オプションの増加も市場拡大に寄与する動向です。遠隔医療とデジタル・ヘルス・プラットフォームの台頭により、自宅でのヘルペス検査キットはより一般的になりつつあり、個人がHSVの状態を知るための便利で、目立たず、利用しやすい方法を提供しています。これらのキットは、ユーザーが自宅でサンプルを採取し、分析のために検査機関に送ることを可能にし、結果は安全なオンライン・プラットフォームを通じて内密に提供されます。これらのサービスが提供する利便性とプライバシーは、より多くの人々、特に若い人々や技術に精通した人々に、自分の性の健康を管理し、検査を受けるよう促しています。

最後に、性感染症の蔓延を減らすことを目的としたヘルスケア・イニシアチブと政府プログラムの増加が、ヘルペスマーカー検査の需要を促進しています。各国政府や世界の保健機関は、ヘルペスやその他の感染症の診断検査へのアクセス拡大を含むSTI予防・管理プログラムに投資しています。このような取り組みと、一般市民の意識の向上や技術の進歩が相まって、ヘルペスマーカー検査市場は今後数年間で着実に成長し、より多くの人々が正確な診断と効果的なケアを受けられるようになると予想されます。

調査対象企業の例（全13件）

  • Abbott Laboratories
  • Abcam PLC
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Luminex Corporation
  • Merck KgaA
  • Meridian Bioscience, Inc.
  • Norgen Biotek Corporation
  • Qiagen NV
  • Quidel Corporation
  • Teco Diagnostics
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP12352

Global Herpes Marker Testing Market to Reach US$654.1 Million by 2030

The global market for Herpes Marker Testing estimated at US$468.1 Million in the year 2023, is expected to reach US$654.1 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$279.9 Million by the end of the analysis period. Growth in the Hospitals End-Use segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$124.1 Million While China is Forecast to Grow at 7.5% CAGR

The Herpes Marker Testing market in the U.S. is estimated at US$124.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$145.7 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Herpes Marker Testing Market - Key Trends and Drivers Summarized

Is Herpes Marker Testing the Key to Effective Management of Viral Infections?

Herpes marker testing plays a critical role in diagnosing and managing herpes simplex virus (HSV) infections, but why is this testing so essential? Herpes marker tests are used to detect the presence of antibodies or viral DNA in the body, helping clinicians identify whether an individual has been infected with HSV-1 or HSV-2, the two most common strains of the virus. HSV-1 is typically associated with oral herpes (cold sores), while HSV-2 is more commonly linked to genital herpes, although both types can infect either region. Herpes infections are widespread, with millions of people worldwide living with either type of the virus, many of whom are unaware they are carriers due to the often asymptomatic nature of the infection.

Herpes marker testing is critical for diagnosing the virus, particularly in asymptomatic individuals or those with mild symptoms, as they can unknowingly transmit the virus to others. Testing for herpes involves identifying specific antibodies (IgG or IgM) that the immune system produces in response to the infection or detecting viral DNA through polymerase chain reaction (PCR) tests. These tests help confirm whether someone has been exposed to the virus and, in many cases, can indicate whether the infection is recent or long-standing. Accurate diagnosis through herpes marker testing is essential for managing outbreaks, reducing the risk of transmission, and guiding treatment options to help individuals manage symptoms and prevent complications.

How Has Technology Advanced Herpes Marker Testing?

Technological advancements have significantly improved herpes marker testing, making it more accurate, faster, and accessible. One of the most significant innovations in this field is the development of polymerase chain reaction (PCR) testing, which allows for the direct detection of viral DNA. PCR testing is highly sensitive and can detect even small amounts of the virus in various sample types, such as blood, saliva, or lesion swabs. This method offers rapid and precise results, often within a few hours, making it one of the most reliable diagnostic tools for detecting active herpes infections. PCR tests have become the gold standard for diagnosing HSV infections, especially in cases where a definitive diagnosis is needed quickly, such as during an acute outbreak.

Serological testing, which identifies the presence of antibodies against HSV, has also improved. Traditional blood tests could sometimes struggle to differentiate between HSV-1 and HSV-2 infections. However, modern serological tests now offer type-specific antibody detection, allowing clinicians to distinguish between the two types of the virus. This distinction is crucial because HSV-1 and HSV-2 have different transmission patterns and recurrence rates, which can influence how a patient manages their infection. Type-specific IgG antibody tests can indicate whether someone has had a past infection, while IgM tests help identify recent or primary infections.

Additionally, point-of-care (POC) testing for herpes is becoming increasingly available. These rapid tests offer on-the-spot results, making them useful in urgent care or sexual health clinics where quick diagnosis is critical. Newer technologies are also exploring multiplex testing, which allows for the simultaneous detection of multiple sexually transmitted infections (STIs) alongside HSV, improving efficiency and reducing the number of tests needed to diagnose co-infections. These advancements in herpes marker testing not only improve diagnostic accuracy but also speed up the process, enabling earlier intervention and better management of herpes infections.

Why Is Herpes Marker Testing Critical for Public Health and Personal Management?

Herpes marker testing is vital for public health and personal management because it enables individuals and healthcare providers to detect and control the spread of herpes simplex virus infections, particularly when symptoms are mild or absent. Many people with herpes are unaware of their infection because it can remain dormant in the body for long periods, only causing outbreaks when triggered by factors like stress, illness, or a weakened immune system. Without proper testing, these individuals may unknowingly transmit the virus to others, contributing to its spread. Testing for herpes markers helps identify carriers and allows them to take precautions, such as using antiviral medications or practicing safer sexual behaviors, to reduce the risk of transmission.

For individuals, herpes marker testing provides clarity and peace of mind, particularly if they are experiencing unexplained symptoms like genital or oral sores, itching, or discomfort. A confirmed diagnosis allows healthcare providers to develop a tailored management plan, which may include antiviral medications like acyclovir, valacyclovir, or famciclovir to reduce the frequency and severity of outbreaks. Knowing their HSV status also empowers individuals to take preventive steps to avoid passing the virus to sexual partners, especially during asymptomatic shedding when the virus can still be transmitted.

In pregnant women, herpes marker testing is particularly critical. HSV infections, especially when acquired during pregnancy, can pose risks to the baby, leading to neonatal herpes, a serious condition that can cause permanent disability or death if not treated promptly. Identifying herpes infections early allows doctors to take preventive measures, such as prescribing antiviral medications in the late stages of pregnancy or recommending a cesarean delivery if there are active lesions during labor, to reduce the risk of transmitting the virus to the newborn.

On a larger scale, herpes marker testing is crucial for managing the overall public health impact of HSV infections. The virus is one of the most prevalent sexually transmitted infections globally, and widespread testing can help reduce its transmission rate by identifying and treating carriers. Early detection and effective management of herpes infections also help reduce the stigma associated with the virus, which can prevent individuals from seeking testing or treatment. By normalizing testing and offering easy access to diagnostics, public health systems can more effectively manage the spread of HSV, protect vulnerable populations, and improve the quality of life for those living with the virus.

What Factors Are Driving the Growth of the Herpes Marker Testing Market?

The growth of the herpes marker testing market is driven by several key factors, including rising awareness of sexually transmitted infections (STIs), advancements in testing technologies, and the increasing prevalence of herpes simplex virus infections globally. One of the primary drivers is the growing awareness of STIs and the importance of regular screening. Public health campaigns and educational programs are encouraging more people to get tested for herpes and other STIs, particularly as awareness increases about the asymptomatic nature of HSV infections. This shift in public health awareness is leading to higher demand for herpes marker testing in clinics, hospitals, and at-home testing kits.

Technological advancements in diagnostic testing are also contributing to the growth of the herpes marker testing market. The development of more accurate, faster, and cost-effective tests, such as PCR and multiplex testing, is making herpes diagnostics more accessible to healthcare providers and patients. These technologies allow for quicker turnaround times, which is especially important in managing acute outbreaks and preventing transmission. The introduction of point-of-care (POC) tests that deliver rapid results is another factor fueling market expansion, particularly in regions where healthcare infrastructure may be limited or where immediate results are necessary for treatment decisions.

The rising prevalence of herpes infections is another significant factor driving market growth. The World Health Organization (WHO) estimates that more than 3.7 billion people under the age of 50 have HSV-1, and over 490 million people aged 15–49 have HSV-2. As these infections remain widespread and incurable, the demand for effective diagnostic tools to manage and monitor herpes infections continues to grow. The increasing recognition of the health risks associated with undiagnosed or untreated herpes, such as complications during pregnancy and heightened risk of HIV transmission, is prompting more individuals to seek testing.

The growth of at-home testing options is another trend contributing to market expansion. With the rise of telemedicine and digital health platforms, at-home herpes testing kits are becoming more popular, providing a convenient, discreet, and accessible way for individuals to learn their HSV status. These kits allow users to collect a sample at home and send it to a laboratory for analysis, with results delivered confidentially via secure online platforms. The convenience and privacy offered by these services are encouraging more people, particularly younger and tech-savvy populations, to take charge of their sexual health and get tested.

Lastly, increasing healthcare initiatives and government programs aimed at reducing the prevalence of sexually transmitted infections are driving demand for herpes marker testing. Governments and global health organizations are investing in STI prevention and control programs, which include expanding access to diagnostic testing for herpes and other infections. These initiatives, combined with greater public awareness and technological advancements, are expected to drive steady growth in the herpes marker testing market in the coming years, ensuring that more individuals can access accurate diagnostics and effective care.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories
  • Abcam PLC
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Luminex Corporation
  • Merck KgaA
  • Meridian Bioscience, Inc.
  • Norgen Biotek Corporation
  • Qiagen NV
  • Quidel Corporation
  • Teco Diagnostics
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Herpes Marker Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Prevalence of Herpes Infections Propels Demand for Herpes Marker Testing
    • Expansion of Diagnostic Testing in Sexual Health Clinics Fuels Market Growth
    • Role of Herpes Marker Testing in Reducing Transmission Rates and Enhancing Public Health Efforts
    • Expansion of Home-based and Self-testing Solutions Strengthens Business Case for Herpes Diagnostics
    • Growth in Digital Health Platforms for Telemedicine Consultations Expands Addressable Market
    • Challenges in Managing Social Stigma and Awareness of Herpes Infections Pose Barriers to Adoption
    • Expansion of Testing in Prenatal Care and High-risk Populations Drives Market Demand
    • Growth in Use of Multiplex Testing Panels for STDs Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Herpes Marker Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Herpes Marker Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Herpes Marker Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Herpes Marker Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Antibody / Antigen-Based Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Antibody / Antigen-Based Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Antibody / Antigen-Based Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Nucleic Acid Amplification-based Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Nucleic Acid Amplification-based Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Nucleic Acid Amplification-based Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Viral Culture Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Viral Culture Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Viral Culture Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • JAPAN
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • CHINA
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • EUROPE
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Herpes Marker Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Herpes Marker Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Herpes Marker Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • FRANCE
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • GERMANY
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Herpes Marker Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Herpes Marker Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Herpes Marker Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • INDIA
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Herpes Marker Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Herpes Marker Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Herpes Marker Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Herpes Marker Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Herpes Marker Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Herpes Marker Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030
  • AFRICA
    • Herpes Marker Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Herpes Marker Testing by End-Use - Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Herpes Marker Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals, Clinics and Academic & Research Institutes for the Years 2014, 2024 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Herpes Marker Testing by Test Type - Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Herpes Marker Testing by Test Type - Percentage Breakdown of Value Sales for Antibody / Antigen-Based Kits, Nucleic Acid Amplification-based Kits and Viral Culture Test for the Years 2014, 2024 & 2030

IV. COMPETITION